Cooper Companies Q2 revenue, profit beat estimates on product launches, strong demand

The Cooper Companies

04/06/2026 21:28

Overview
US medical device maker's fiscal Q2 revenue grew 8%, beating analyst expectations
Adjusted EPS for fiscal Q2 rose 26% yr/yr and beat analyst expectations
GAAP EPS declined due to litigation charge from CooperSurgical product recall

Outlook
Cooper Companies sees fiscal 2026 revenue of $4.285-$4.321 bln, organic growth of 3.5%-4.5%
Company expects fiscal 2026 non-GAAP diluted EPS of $4.58-$4.66
Cooper Companies reaffirms long-term free cash flow objective exceeding $2.2 bln for 2026-2028

Result Drivers
NEW PRODUCT LAUNCHES AND DEMAND - Co said revenue growth was driven by new product launches and favorable demand across its businesses
LITIGATION CHARGE - GAAP results were impacted by a $271.6 mln litigation-related charge linked to a December 2023 CooperSurgical product recall
OPERATIONAL DISCIPLINE AND SYNERGIES - Non-GAAP operating margin improved due to disciplined execution and synergies from last year's reorganization

Company press release: ID:nGNX5vgBJg

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$1.08 bln
$1.05 bln (14 Analysts)
Q2 Adjusted EPS
Beat
$1.21
$1.10 (15 Analysts)
Q2 EPS
 
-$0.40
 
Q2 Gross Margin
 
68%
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Cooper Companies Inc is $87.89, about 45.6% above its June 3 closing price of $60.34
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 18 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)